XM does not provide services to residents of the United States of America.
G
G

Getinge


News

Getinge CEO Buys Shares

BRIEF-Getinge CEO Buys Shares Sept 5(Reuters) - Getinge AB GETIb.ST : SAID ON WEDNESDAY CEO OF GETINGE AB MATTIAS PERJOS BUYS 20,000 SHARES AT PRICE ABOUT SEK 218.0771 PER SHARE ON SEPTEMBER 4TH Source text for Workspace: [ Full Story ] Further company coverage: [GETIb.ST] (Gdansk Newsroom)
G

Getinge Makes A Provision Of MBRL 240 Related To Brazilian Investigation

BRIEF-Getinge Makes A Provision Of MBRL 240 Related To Brazilian Investigation Sept 1 (Reuters) - Getinge AB GETIb.ST : GETINGE MAKES A PROVISION OF MBRL 240 RELATED TO BRAZILIAN INVESTIGATION GETINGE - FINAL AND DEFINITIVE COSTS WILL BE DETERMINED WHEN SETTLEMENT NEGOTIATIONS ARE CONCLUDED GETINGE - PROVISION WILL BE REPORTED AS AN ITEM AFFECTING
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Updates: Schenker Aug 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Deutsche Bahn's logistics unit Schenker has received final bids from Danish transport firm DSV DSV.CO and a consortium led by CVC Capital Partners CVC.AS , with each valuing the business at around 14 billion euros ($15.6 billion), two people familiar with the matter told Reuters.
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Aug 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday: ** Deutsche Bahn's logistics unit Schenker has collected final bids from a consortium led by CVC Capital Partners CVC.AS and Danish transport firm DSV DSV.CO that value the business at around 14 billion euros ($15.57 billion), two people familiar with the matter told Reuters.
G

Paragonix Technologies Signs Definitive Agreement To Be Acquired By Getinge

BRIEF-Paragonix Technologies Signs Definitive Agreement To Be Acquired By Getinge Aug 22 (Reuters) - Getinge AB GETIb.ST : PARAGONIX TECHNOLOGIES SIGNS DEFINITIVE AGREEMENT TO BE ACQUIRED BY GETINGE Source text for Eikon: ID:nBw6XvskYa Further company coverage: [GETIb.ST]
G

Getinge To Acquire Paragonix Technologies

BRIEF-Getinge To Acquire Paragonix Technologies Aug 22 (Reuters) - Getinge AB GETIb.ST : GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET GETINGE- PROPOSED DEAL FOR APPROXIMATELY USD 477 MILLION. Source text for Eikon: ID:nPnblMm1na Further company coverage: [GETIb.ST]
G

Swedish firm Getinge to buy Paragonix Technologies for about $477 mln

Swedish firm Getinge to buy Paragonix Technologies for about $477 mln Aug 22 (Reuters) - Swedish medical-equipment maker Getinge GETIb.ST said on Thursday it will acquire U.S.-based organ transport company Paragonix Technologies for about $477 million. Getinge will acquire all the issued and outstanding shares of the privately-held Paragonix on a cash and debt-free basis, adding that the initial payout related to the acquisition will be financed through a bridge loan provided by Swedish bank SEB
G

Getinge Says Co To Acquire Paragonix Technologies For USD 477 Mln

BRIEF-Getinge Says Co To Acquire Paragonix Technologies For USD 477 Mln Aug 22 (Reuters) - Getinge AB GETIb.ST : GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET GETINGE AB - ACQUIRES PARAGONIX TECHNOLOGIES FOR USD 477 MILLION GETINGE - AGGREGATED UPFRONT PURCHASE PRICE OF $477 MILLION, OF WHICH USD 253
G

Anglo American, Rio Tinto, Unilever

EUROPE RESEARCH ROUNDUP-Anglo American, Rio Tinto, Unilever July 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Anglo American, Rio Tinto and Unilever, on Tuesday. HIGHLIGHTS * Anglo American Plc AAL.L : HSBC cuts target price to 2,300p from 2,450p * Antofagasta Plc ANTO.L : HSBC raises target price to 1,400p from 1,100p * Belimo Holding AG BEAN.S : Jefferies raises target price to CHF 598 from CHF 498 * Rio Tinto RIO.L : HSBC
A
A
A
B
B
D
E
F
G
G
G
P
T
W
A
A
B
G
R

Barclays, Mips AB, Novo Nordisk

EUROPE RESEARCH ROUNDUP-Barclays, Mips AB, Novo Nordisk July 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Barclays, Mips AB and Novo Nordisk on Friday. HIGHLIGHTS * Barclays BARC.L : Jefferies raises target price to 341p from 335p * Mips AB MIPS.ST : Jefferies raises to buy from hold * Novo Nordisk NOVOB.CO : HSBC raises target price to DKK 1150 from DKK 1030 * Spectris SXS.L : HSBC raises target price to 3750p from 3425p * S
A
A
B
B
B
B
B
C
D
E
E
E
G
H
H
H
K
S
S
S
T
A
A

European shares end marginally lower as tech sell-off stymies advances

UPDATE 3-European shares end marginally lower as tech sell-off stymies advances For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 closes down 0.2% ECB keeps rates unchanged at 3.75% Volvo Cars rise on Q2 adjusted EBIT beat Husqvarna slides on Q2 sales drop Updated at 1600 GMT By Shristi Achar A, Pranav Kashyap and Shashwat Chauhan July 18 (Reuters) - European shares ended lower on Thursday as a continued selloff of chip stocks ke
A
G
H
N
V
E
F
S
G

Getinge rises after Q2 earnings beat

BUZZ-Getinge rises after Q2 earnings beat ** Shares in Getinge GETIb.ST rise around 7% after the Swedish medical equipment maker's Q2 earnings beat expectations ** EBITA, adjusted for items affecting comparability, came in at 981 million Swedish crowns ($93 million) vs analysts' expectations of 829 million crowns ** Group sales came in 4.7% ahead o
G

Medical gear maker Getinge tops Q2 profit forecast as orders grow

UPDATE 3-Medical firm Getinge jumps as rising orders fuel profit beat Adds share move in paragraph 2, analyst comment in -7 By Greta Rosen Fondahn July 18 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST beat second-quarter earnings forecasts on Thursday as its order intake rose despite some problems with its packaging and heart products.
G

Medical gear maker Getinge beats Q2 core profit expectations

Medical gear maker Getinge beats Q2 core profit expectations July 18 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST reported bigger-than-expected core earnings for the second quarter on Thursday, as its order intake grew organically in the period. Reporting by Greta Rosen Fondahn in Gdansk; editing by Milla Nissi
G

Nordic corporate earnings week ahead

DIARY-Nordic corporate earnings week ahead July 12 (Reuters) - Diary of Nordic (OMXS30-SK, OBX-OS, OMXHPI-HE, OMXC20) corporate earnings for the week ahead NORDIC EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 15-Jul-2024 NTS ORK.OL Orkla ASA Q2 2024 Orkla ASA Earnings Release 17-Jul-2024 05:00 NEL.OL Nel ASA Q2 2024 Nel ASA Earnings Release 18-Jul-2024 NTS TEL.OL Telenor ASA Q2 2024 Telenor ASA Earnings Release 18-Jul-2024 NTS PGS.OL^G24 5088687729 PGS ASA Tgs Newco AS Q2 2024
A
B
D
E
E
E
G
K
K
N
O
P
S
S
T
T
V
W
A
A
S
T
Y

Getinge Extends, Elevates Partnership With Universeum

BRIEF-Getinge Extends, Elevates Partnership With Universeum July 5 (Reuters) - Getinge AB GETIb.ST : EXTENDS AND ELEVATES PARTNERSHIP WITH UNIVERSEUM Further company coverage: [GETIb.ST] (Gdansk Newsroom)
G

Hargreaves Lansdown, Segro, Umicore

EUROPE RESEARCH ROUNDUP-Hargreaves Lansdown, Segro, Umicore June 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Hargreaves Lansdown, Segro and Umicore, on Wednesday. HIGHLIGHTS * GEA Group AG G1AG.DE : Jefferies raises to buy from hold * Hargreaves Lansdown HRGV.L : Jefferies cuts to hold from buy * Oxford Instruments OXIG.L : Berenberg raises target price to 2,945p from 2,640p * Segro SGRO.L : Jefferies cuts to hold from buy *
A
A
B
B
B
B
B
B
B
D
D
G
G
G
G
G
H
H
I
K
K
L
M
R
S
S
S
U
U
V
A
S



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.